Literature DB >> 12130523

Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism.

Ingrid Pabinger1, Helga Grafenhofer, Paul A Kyrle, Peter Quehenberger, Christine Mannhalter, Klaus Lechner, Alexandra Kaider.   

Abstract

There is strong evidence that the incidence of venous thromboembolism (VTE) is increased during pregnancy. However, it is unknown whether and to which extent pregnancy influences the risk for recurrent VTE in women with previous thrombosis. To investigate whether pregnancy temporarily increases the risk for recurrent thrombosis, we retrospectively evaluated the recurrence rate in 109 women who had at least one pregnancy after an episode of VTE by comparing the time period during pregnancy with the nonpregnant period. Forty-three women had a first recurrence during a total observation time of 1014 years. Eight events (73 observation years) occurred during pregnancy, and 35 events (941 observation years) occurred outside pregnancy. Recurrence rates per 100 patient-years were 10.9% during and 3.7% outside pregnancy. Relative risk during pregnancy was 3.5 (95% confidence interval, 1.6-7.8; P =.002). Our data suggest that pregnancy leads to a temporary increase in the risk for recurrent thrombotic events.

Entities:  

Mesh:

Year:  2002        PMID: 12130523     DOI: 10.1182/blood-2002-01-0149

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Hematologic complications of pregnancy.

Authors:  Danielle M Townsley
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

3.  Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Authors:  Mark H Eckman; Pablo Alonso-Coello; Gordon H Guyatt; Shanil Ebrahim; Kari A O Tikkinen; Luciane Cruz Lopes; Ignacio Neumann; Sarah D McDonald; Yuqing Zhang; Qi Zhou; Elie A Akl; Ann Flem Jacobsen; Amparo Santamaría; Joyce Maria Annichino-Bizzacchi; Wael Bitar; Per Morten Sandset; Shannon M Bates
Journal:  Thromb Res       Date:  2015-05-22       Impact factor: 3.944

4.  Antithrombin deficiency in pregnancy.

Authors:  Shivani Durai; Lay Kok Tan; Serene Lim
Journal:  BMJ Case Rep       Date:  2016-05-20

Review 5.  Duration of anticoagulation after cerebral venous sinus thrombosis.

Authors:  Frances Caprio; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

6.  Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception.

Authors:  Caitlin Bernard; Chelsea Pekny; Christabell O Omukagah; Christian O Bernard; Imran Manji; Sonak D Pastakia; Astrid Christoffersen-Deb
Journal:  Contraception       Date:  2018-08-01       Impact factor: 3.375

7.  Venous thromboembolism in pregnancy.

Authors:  Marcelo P Villa-Forte Gomes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

Review 8.  Pulmonary embolism in pregnancy.

Authors:  E Conti; L Zezza; E Ralli; C Comito; L Sada; J Passerini; D Caserta; S Rubattu; C Autore; M Moscarini; M Volpe
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

Review 9.  Pregnancy-associated thrombosis.

Authors:  Ingrid Pabinger; Helga Grafenhofer
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

10.  Tinzaparin safety and efficacy in pregnancy.

Authors:  A Khalifeh; J Grantham; J Byrne; K Murphy; F McAuliffe; B Byrne
Journal:  Ir J Med Sci       Date:  2013-08-11       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.